Fiasp® flaws: are faster insulins worth it? - Diabetes Voice
Integrated Insulin Pump and Continuous Glucose Monitoring Technology in Diabetes Care Today: A Perspective of Real-Life Experience With the Minimed™ 670G Hybrid Closed-Loop System - Endocrine Practice
Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes | Diabetes Technology & Therapeutics
Insulin Pens: Types, Storage Tips & How to Use Them
New Diabetes Technology: What to Expect in 2021
New closed-loop insulin systems | SpringerLink
FDA OKs Novo Nordisk's Fiasp for infusion pumps - MassDevice
Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation - Annette Baumstark, Jochen Mende, Joji Uchiyama, Cornelia Haug, Guido Freckmann, 2022
Insulin 100 years
EU Approves Novo Nordisk's Pre-filled Insulin Cartridge for the New Accu-Chek Insight Insulin Pump
Novo Nordisk launching additional US insulin affordability offerings in January 2020
Glooko Announces Collaboration with Novo Nordisk for European Connected Pen Launches - Glooko
FDA Approves Ozempic, Novo Nordisk's New Type 2 Diabetes Treatment
Novo Nordisk Insulin Pen Certification | novoMEDLINK™
Insulet gives go-ahead for more TV ads, prepping for Omnipod 5 launch later this year | Fierce Pharma
In milestone trial, experimental drug delays type 1 diabetes | Science | AAAS
Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps
New Diabetes Technology: What to Expect in 2021
Treating Type 2 Diabetes | Medtronic
Insulin Pens - Children with Diabetes
Treating Type 2 Diabetes | Medtronic
Novo Nordisk introduces NovoRapid PumpCart insulin pump
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis - ScienceDirect
